All times are listed in CEST (Central European Summer Time)

Browsing Over 1606 Presentations

Sort By
Industry Satellite Symposium

Discussion and conclusions

Speakers
  • Peter Reichardt (Berlin, Germany)
Session Name
Deciphera Pharmaceuticals - From clinical trial to clinical practice: novel strategies for treating patients with advanced GIST
Location
7.1.D - Dijon Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Panel Discussion

Speakers
  • Sylvie Lorenzen (Munich, Germany)
  • Antoine Adenis (Montpellier, Cedex 5, France)
  • Hanneke W. Van Laarhoven (Amsterdam, Netherlands)
Session Name
Novartis - Guiding Through Oesophageal Cancer: Expert Insights on the Patient Journey From Diagnosis to Treatment
Location
7.3.G - Grenoble Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Understanding the Foundational Concepts of HER2-Low Breast Cancer: Challenges and Opportunities of an Evolving Definition

Speakers
  • Paolo Tarantino (Boston, United States of America)
Session Name
PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Location
7.3.H - Honfleur Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Welcome and Introduction

Speakers
  • Myriam Chalabi (Amsterdam, Netherlands)
Session Name
Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges
Location
7.3.O - Orléans Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Close

Speakers
  • Ian Chau (Sutton, United Kingdom)
Session Name
Bristol Myers Squibb - GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges
Location
7.3.O - Orléans Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

New Perspectives with Targeted Options for KRAS -Driven Tumors

Speakers
  • Shirish M. Gadgeel (Detroit, United States of America)
Session Name
Mirati Therapeutics, Inc. - Advancing Tailored Therapies in NSCLC and KRASG12C-Driven Tumors
Location
7.2.E - Évry Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Quiz questions revisited

Speakers
  • Julien Mazieres (Toulouse, France)
Session Name
ACE Oncology - Navigating Treatment Decisions in Advanced NSCLC: Update on Molecular Testing and New Targeted Treatment Options
Location
7.3.Q - Quimper Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Scope of treatment through progressive lines in metastatic GIST: stable disease and QoL

Speakers
  • Antoine Italiano (Bordeaux, France)
Session Name
Deciphera Pharmaceuticals - From clinical trial to clinical practice: novel strategies for treating patients with advanced GIST
Location
7.1.D - Dijon Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Panel Case Discussion

Speakers
  • Sylvie Lorenzen (Munich, Germany)
  • Antoine Adenis (Montpellier, Cedex 5, France)
  • Hanneke W. Van Laarhoven (Amsterdam, Netherlands)
Session Name
Novartis - Guiding Through Oesophageal Cancer: Expert Insights on the Patient Journey From Diagnosis to Treatment
Location
7.3.G - Grenoble Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Panel Discussion

Speakers
  • Sylvie Lorenzen (Munich, Germany)
  • Antoine Adenis (Montpellier, Cedex 5, France)
  • Hanneke W. Van Laarhoven (Amsterdam, Netherlands)
Session Name
Novartis - Guiding Through Oesophageal Cancer: Expert Insights on the Patient Journey From Diagnosis to Treatment
Location
7.3.G - Grenoble Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Exploring the Nuances of HER2-Targeted Treatment Selection for Patients With HER2-Low Breast Cancer: Expert Insights Into Implications for Practice and Team-Based Approaches to Individualizing Patient Care

Speakers
  • Aleix Prat (Barcelona, Spain)
  • Paolo Tarantino (Boston, United States of America)
  • Shanu Modi (New York, United States of America)
Session Name
PeerView Oncology - Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Location
7.3.H - Honfleur Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45
Industry Satellite Symposium

Unmet Needs and Recent Advances for NSCLC

Speakers
  • Jarushka Naidoo (Dublin, Ireland)
Session Name
Mirati Therapeutics, Inc. - Advancing Tailored Therapies in NSCLC and KRASG12C-Driven Tumors
Location
7.2.E - Évry Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Fri, 09.09.2022
Time
10:15 - 11:45